FARCX | VGSIX | FARCX / VGSIX | |
Total Expense Ratio | 0.93 | 0.27 | 344% |
Annual Report Gross Expense Ratio | 1.02 | 0.27 | 378% |
Fund Existence | 30 years | 29 years | - |
Gain YTD | 1.677 | 4.920 | 34% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 880M | 63.8B | 1% |
Annual Yield % from dividends | 3.57 | 3.75 | 95% |
Returns for 1 year | 0.03 | 8.10 | 0% |
Returns for 3 years | -12.41 | 9.41 | -132% |
Returns for 5 years | -1.11 | 41.03 | -3% |
Returns for 10 years | -16.39 | 63.27 | -26% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
APCB | 29.40 | 0.02 | +0.07% |
ActivePassive Core Bond ETF | |||
XTR | 29.03 | N/A | N/A |
Global X S&P 500® Tail Risk ETF | |||
BIB | 52.55 | -0.07 | -0.14% |
ProShares Ultra Nasdaq Biotechnology | |||
FICS | 39.48 | -0.15 | -0.38% |
First Trust Intl Developed Cap Strth ETF | |||
IJR | 112.91 | -1.24 | -1.09% |
iShares Core S&P Small-Cap ETF |